You searched for Antibody candidate - Page 65 of 69

mereo biopharma brittle bone disease osteogenesis imperfecta

More News! 11 Nov 2019

Mereo BioPharma’s Brittle Bone Disease Drug Stumbles in Phase II

…bone disease. Mereo tested different doses of its antibody drug in 112 adults with osteogenesis imperfecta in a 12-month phase IIb trial. The drug failed to meet the main endpoint…

November 11, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Feb 2023

Disc Medicine raises $62.5M for hematology programs

…DISC-0974 (hepcidin suppression) is another treatment in the pipeline. It is a first-in-class, investigational, anti-hemojuvelin (HJV) monoclonal antibody designed to suppress hepcidin production and increase serum iron to enable erythropoiesis….

February 14, 2023 - 2 minutesmins - By Jim Cornall

Interview 27 Mar 2017

Meet one of the Most Successful Biotech Entrepreneurs in the UK

…Molecular Genetics at Leicester, and then a postdoc at Bath on antibody engineering, before moving to Cambridge to work at the GURDON Institute. It was during his postdoc and his…

March 27, 2017 - 7 minutesmins - By Philip Hemme

News and Trends 21 Feb 2023

Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders

…Maraganore, chair of Hemab’s board of directors. About HMB-001 HMB-001 is bispecific antibody that binds and stabilizes endogenous factor VIIa (FVIIa) with one antibody arm and TLT-1 on activated platelets…

February 21, 2023 - 2 minutesmins - By Jim Cornall

morphosys novartis muscle simb bimagrumab

News and Trends 27 Apr 2016

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

MorphoSys confirms that its antibody (bimagrumab) failed to meet the primary endpoint of a phase IIb/III trial for a muscle disease (sIBM), conducted by Novartis. Sad news for Novartis and…

April 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 8 Mar 2023

Affibody and Chiesi Group to develop treatments for respiratory diseases

…commercial milestone payments up to $637 million plus mid-single to low double-digit royalties on sales. About Affibody molecules Affibody molecules are a novel class of antibody mimetics with characteristics surpassing…

March 8, 2023 - 3 minutesmins - By Jim Cornall

lupus neovacs stellar limpet protein autoimmune immunotherapy biotech

News and Trends 21 Jan 2016

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

…met the CEO of Neovacs, Miguel Sieler, at BIO-Europe in November. Sieler explained how their kinoids are used to stimulate a polyclonal antibody response to a specific cytokine used (depending…

January 21, 2016 - 2 minutesmins - By Dani Bancroft

frederic gault coral microbiome interview cancer biotech immunooncology palytoxin adc

News and Trends 14 Apr 2016

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

…antibodies – i.e. Antibody Drug Conjugate technology (ADC) – to directly administer the toxin to tumors.This would increase the efficiency of the drug, whilst reducing the number of doses needed,…

April 14, 2016 - 5 minutesmins - By Marie Godar

Best in Biotech 15 May 2018

Here Are 10 of the Hottest Biotech Hubs in Europe

…Planegg. Right there is one of Europe’s largest biotechs: MorphoSys, a billion-euro biotech that develops antibody therapies. The city is also home to Medigene, which develops T cell receptor technology…

May 15, 2018 - 10 minutesmins - By Clara Rodríguez Fernández

alpaca nejm purpura thrombocytopenia blood titan hercules

News and Trends 16 Feb 2016

World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies

Ablynx, the llama antibody biotech in Belgium, has now proven to be on solid ground regarding their orphan drug for a rare blood disease. Now the New England Journal of…

February 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 1 Nov 2022

Human Immunology Biosciences launches with $120M

…enhancements that come with our approach.” Clinical-stage assets HI-Bio’s clinical-stage assets include felzartamab, an anti-CD38 antibody, and HIB210, an anti-C5aR1 antibody. Felzartamab targets a protein expressed on the surface of…

November 1, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 28 Feb 2023

10 biotech companies making a difference in rare diseases

…Founded: 2019 Alchemab Therapeutics is a biotechnology company working on harnessing the power of the immune system to create the next generation of antibody therapeutics for hard-to-treat diseases that do…

February 28, 2023 - 11 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Mereo BioPharma’s Brittle Bone Disease Drug Stumbles in Phase II

Disc Medicine raises $62.5M for hematology programs

Meet one of the Most Successful Biotech Entrepreneurs in the UK

Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders

‘Disappointing results’ for Novartis & MorphoSys phase III in Muscle Disease

Affibody and Chiesi Group to develop treatments for respiratory diseases

Fighting Lupus with an Autoimmune Disease Vaccine that Uses Limpet Proteins

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

Here Are 10 of the Hottest Biotech Hubs in Europe

World’s Best Journal in Medicine Publishes on Phase II Llama Antibodies

Human Immunology Biosciences launches with $120M

10 biotech companies making a difference in rare diseases

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!